Thrombolysis in stroke:: Inappropriate consideration of the 'window period' as the time available

被引:16
作者
Maestre-Moreno, JF
Fernández-Pérez, MD
Arnáiz-Urrutia, C
Mínguez, A
Navarrete-Navarro, P
Martínez-Bosch, J
机构
[1] Hosp Virgen Nieves, Serv Neurol, E-18013 Granada, Spain
[2] Hosp Virgen Nieves, Serv Cuidados Criticos & Urgencias, E-18013 Granada, Spain
[3] Hosp Virgen Nieves, Serv Neurorradiol, E-18013 Granada, Spain
关键词
delay; health care organisation; intravenous thrombolysis; ischaemic stroke; r-TPA; therapeutic attitude;
D O I
10.33588/rn.4005.2004356
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims. The earlier r-TPA is administered in ischaemic strokes, the more effective it is. The aim of this study is to analyse the delay times in health care afforded in a consecutive series of cases that had received treatment, with a view to shortening them. Patients and methods. We analysed the medical records of the first patients to be treated in our centre. The paper describes several variables involving demographic and clinical factors, as well as the delay in entering the Emergency department, performing a CAT scan and especially the time elapsed between the CAT scan and starting treatment. We have examined the existence of an inappropriate correlation between delays that should be independent of one another. Results. The mean age of the 17 patients treated was 68 years and they had a stroke severity score of 17 points on the NIHSS. The mean time of delay until arrival, arrival-CAT and CAT-treatment were slightly under I hour each, and onset-treatment delay was 165 minutes, which is very close to the limit of the therapeutic window period. We found a strong inverse linear association between the time elapsed between onset and the CAT scan, and from the latter to the beginning of treatment (Spearman's r -0.664, p = 0.004). Conclusions. Findings indicate that in our hospital, as in other centres in the initial phases of implementation, the therapeutic time window for intravenous thrombolysis in ischaemic stroke tends to run out. It must be highlighted that the resolve of the physician who indicates the treatment exerts a decisive effect on the delay.
引用
收藏
页码:274 / 278
页数:5
相关论文
共 10 条
[1]   Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study [J].
Albers, GW ;
Bates, VE ;
Clark, WM ;
Bell, R ;
Verro, P ;
Hamilton, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1145-1150
[2]  
Alvarez Sabin J, 1999, Med Clin (Barc), V113, P481
[3]   Stroke code impact on the efficacy of thrombolytic treatment [J].
Alvarez-Sabín, J ;
Molina, CA ;
Abilleira, S ;
Montaner, J ;
Alfranca, FG ;
Fabrega, XJ ;
Arenillas, J ;
Huertas, R ;
Ribó, M ;
Quintana, M ;
Codina, A .
MEDICINA CLINICA, 2003, 120 (02) :47-51
[4]  
*ATLANTIS ECASS NI, 2004, LANCET, V363, P769
[5]   Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy [J].
Barber, PA ;
Demchuk, AM ;
Zhang, JJ ;
Buchan, AM .
LANCET, 2000, 355 (9216) :1670-1674
[6]  
BRODERICK JP, 1997, DRUGS S3, V54, P116
[7]   Intravenous tissue plasminogen activator for acute ischemic stroke - A Canadian hospital's experience [J].
Chapman, KM ;
Woolfenden, AR ;
Graeb, D ;
Johnston, DCC ;
Beckman, J ;
Schulzer, M ;
Teal, PA .
STROKE, 2000, 31 (12) :2920-2924
[8]   Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review [J].
Kwan, J ;
Hand, P ;
Sandercock, P .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2004, 97 (05) :273-279
[9]  
*REG SITS MOST, 2004, SAF IMPL THROMB STRO
[10]   Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital [J].
Szoeke, CEI ;
Parsons, MW ;
Butcher, KS ;
Baird, TA ;
Mitchell, PJ ;
Fox, SE ;
Davis, SM .
MEDICAL JOURNAL OF AUSTRALIA, 2003, 178 (07) :324-328